
The transition towards sustainable pharmaceuticals – assessing sustainability, from design & production to prescription & use
blog, General
Prioritization and selection of APIs using a risk-based approach
blogBy Cristiana Cannata, PhD researcher in Environmental Science at Radboud University (Nijmegen, The Netherlands) & contributor of PREMIER WP1.2
There are more than 1500 active pharmaceutical ingredients (APIs) on the European market. Residues…

Ecotoxicity testing: guidelines and evaluation
blogBy Alice Marshall, PhD researcher in Environmental Toxicology at University of York & contributor of PREMIER WP2.1; and Caroline Moermond, Sr Policy Advisor at the National Institute for Public Health and the Environment (RIVM), lead…

PREMIER workshop on ‘What constitutes a more environmentally friendly API?’
blog
By Dr. Caroline Moermond, The Dutch National Institute for Public Health and the Environment (RIVM)
On February 2, 2021 a consortium-wide workshop was held with more than 20 participants from all PREMIER work packages. They discussed…

PREMIER welcomes ERA Data on APIs & API Testing Tips!
blogShare your environmental risk assessment (ERA) data & testing tips on active pharmaceutical ingredients (APIs) to help us build the world’s leading publicly available repository on ERA data for pharmaceuticals.
PREMIER is currently…